A detailed history of Kennedy Capital Management, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 145,349 shares of AXGN stock, worth $2.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
145,349
Previous 293,536 50.48%
Holding current value
$2.1 Million
Previous $2.13 Million 4.14%
% of portfolio
0.05%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $1.11 Million - $2.18 Million
-148,187 Reduced 50.48%
145,349 $2.04 Million
Q2 2024

Aug 14, 2024

SELL
$5.67 - $8.06 $7,098 - $10,091
-1,252 Reduced 0.42%
293,536 $2.13 Million
Q1 2024

May 15, 2024

SELL
$6.63 - $10.69 $29,264 - $47,185
-4,414 Reduced 1.48%
294,788 $2.38 Million
Q4 2023

Feb 14, 2024

SELL
$3.61 - $7.76 $18,248 - $39,226
-5,055 Reduced 1.66%
299,202 $2.04 Million
Q4 2022

Feb 14, 2023

SELL
$9.44 - $13.09 $2,718 - $3,769
-288 Reduced 0.09%
304,257 $3.04 Million
Q3 2022

Nov 14, 2022

SELL
$8.14 - $12.25 $4,525 - $6,811
-556 Reduced 0.18%
304,545 $3.63 Million
Q2 2022

Aug 10, 2022

BUY
$6.99 - $10.0 $575,542 - $823,380
82,338 Added 36.96%
305,101 $2.5 Million
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $251,638 - $370,872
-34,661 Reduced 13.46%
222,763 $1.77 Million
Q4 2021

Feb 14, 2022

SELL
$8.8 - $16.0 $229,618 - $417,488
-26,093 Reduced 9.2%
257,424 $2.41 Million
Q3 2021

Nov 15, 2021

BUY
$15.23 - $21.72 $468,398 - $667,998
30,755 Added 12.17%
283,517 $4.48 Million
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $4.5 Million - $5.94 Million
252,762 New
252,762 $5.46 Million
Q4 2018

Feb 12, 2019

SELL
$17.09 - $38.25 $3.39 Million - $7.58 Million
-198,143 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$34.05 - $55.9 $544,323 - $893,617
15,986 Added 8.78%
198,143 $7.3 Million
Q2 2018

Aug 14, 2018

BUY
$36.15 - $52.5 $6.58 Million - $9.56 Million
182,157 New
182,157 $9.15 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $612M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.